Massachusetts Financial Services Co. MA Has $295.20 Million Position in Astera Labs, Inc. $ALAB

Massachusetts Financial Services Co. MA grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 46.6% in the third quarter, HoldingsChannel reports. The fund owned 1,507,675 shares of the company’s stock after buying an additional 479,360 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Astera Labs were worth $295,203,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. FengHe Fund Management Pte. Ltd. bought a new stake in shares of Astera Labs in the second quarter valued at approximately $106,772,000. 1832 Asset Management L.P. grew its position in Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares in the last quarter. Holocene Advisors LP bought a new position in Astera Labs during the 2nd quarter worth $55,827,000. Finally, State Street Corp increased its stake in Astera Labs by 39.3% during the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after acquiring an additional 604,363 shares during the period. 60.47% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer directly owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. The trade was a 5.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel directly owned 147,040 shares of the company’s stock, valued at $21,275,217.60. This represents a 3.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 576,936 shares of company stock valued at $87,409,540 over the last three months. Insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday. BNP Paribas Exane started coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating and a $225.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Needham & Company LLC lifted their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Roth Capital boosted their price objective on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $190.63.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $182.00 on Monday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a market cap of $30.74 billion, a price-to-earnings ratio of 163.96, a PEG ratio of 2.48 and a beta of 1.50. The firm has a 50 day simple moving average of $159.80 and a 200 day simple moving average of $166.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company’s revenue for the quarter was up 103.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.